Mercachem logo voor websites

Update COVID-19:

The COVID-19 situation is currently impacting most of the globe, including Asia, Europe and North America. At all MercachemSyncom sites, we follow the recommendations of the local competent authorities as they are released. We have established a series of contingency measures aimed at reducing risks for our employees, their families and the MercachemSyncom Operations. These measures are proactively being reassessed at regular intervals and adapted as deemed appropriate.

The MercachemSyncom team is united and determined to face the situation with the energy, strength and passion that constitute one of our hallmarks.

33000ELFCompoundsPrepared 72dpi

Over 1000 scaffolds have been evaluated by the library selection committee (WP10) in which Mercachem was represented by Jorg Benningshof. The experimental validation (WP11) of 319 scaffolds has successfully been accomplished under the supervision of Jorg Benningshof.

A total of 40.006 compounds were produced on validated scaffolds at a steady rate at Mercachem.

The efforts of the library selection committee have been published in a recent paper in Drug Discovery Today, which comments on the achievements and prospects of the ELF Project.